Medical Properties Trust Inc. (NYSE:MPW) does about 3.48M shares in volume on a normal day but saw 4783662 shares change hands in Monday trading. The company now has a market cap of 9.88B USD and an enterprise value of about $17.42B. Its current market price is $18.58, marking an increase of 0.05% compared to the previous close of $18.57. The 52 week high reached by this stock is $24.29 whilst the lowest price level in 52 weeks is $12.35. The script in recent trading has seen the stock touch a high of $18.67 and a low of $18.45.
Medical Properties Trust Inc. (MPW) has a 20-day trading average at $19.14 and the current price is -23.50% off the 52-week high compared with 50.45% distance from its 52-week low. The 50-day simple moving average of the closing price is $18.95 and its 200-day simple moving average is $19.44. If we look at the stock’s price movements over the week, volatility stands at 1.95%, which increases to 2.39% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 42.50 to suggest the stock is neutral.
The consensus objective for the share price is $21.08, suggesting that the stock has a potential upside of 11.86% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 24, 2020 when Mizuho upgraded the stock to “Buy” and issued a price target of between $20 and $23. Deutsche Bank downgraded the stock to “Hold” from Buy on July 10, 2020 at a price target of $19. Mizuho downgraded its price target at $27-$19.
The current price level is -3.25%, -2.01%, and -4.44% away from its SMA20, SMA50, and SMA200 respectively, with the MPW price moving above the 50-day SMA on August 31. Medical Properties Trust Inc. (MPW) stock is down -1.17% over the week and -7.70% over the past month. Its price is -11.98% year-to-date and -0.05% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of $0.21 below consensus estimates by -$0.05. MPW’s earnings per share are forecast to grow by 3.40% this year and 25.60% over next year. Expected sales for next quarter are $327.23 million, which analysts say will come at $1.24 billion for the current fiscal year and next year at $1.37 billion. In addition, estimates put the company’s current quarterly revenue at an average of $320.46 million.
To reach the target analysts have set, the stock logically needs to grow 11.86 percent from here.
Outstanding shares total 527.78M with insiders holding 1.23% of the shares and institutional holders owning 84.31% of the company’s common stock. The company has a return on investment of 4.00% and return on equity of 6.00%. The price to earnings ratio (P/E ratio) amounts to 22.58 while the forward price to earnings ratio is 16.30. The beta has a value of 0.54. Price to book ratio is 1.39 and price to sales ratio is 9.26.
According to a U.S. Securities and Exchange Commission filing, Vanguard Real Estate Index Fund has reduced its position in Medical Properties Trust Inc. (MPW) to 23,225,064 shares, mirroring a recent drop by -0.56%. Vanguard Real Estate Index Fund dumped -0.13 million shares of Medical Properties Trust Inc. common stock bringing its total worth to about $467.52 million at the end of recent close, SEC documents show. Vanguard Real Estate Index Fund isn’t the only investment manager who changed stakes and is followed by Vanguard Total Stock Market Index, which sold off 46202.0 shares to end up with 15,008,500 shares worth $302.12 million. iShares Core S&P Mid Cap ETF cut their holdings by -0.53% in the company over the course of the most recent quarter. It now holds a 2.65% position in Medical Properties Trust Inc. thanks to 14.01 million shares amounting to $281.95 million.